All In Biotech

Drug Trial Radar · NCT05591222

Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Investigate the Efficacy and Safety of Daxdilimab Subcutaneous Injection in Reducing Disease Activity in Adult Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

72

Actual

Start

Dec 29, 2022

Primary completion

May 8, 2025

Study completion May 8, 2025

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 24, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2, double-blind, randomized, placebo-controlled parallel-group study to evaluate the efficacy and safety of daxdilimab in participants with moderate-to-severe active primary Discoid Lupus Erythematosus (DLE) refractory to standard of care.

Conditions

  • Discoid Lupus Erythematosus

Interventions

  • PlaceboDrug

    Placebo will be administered subcutaneously as two injections for each dose.

  • DaxdilimabDrug

    Daxdilimab will be administered subcutaneously as two injections for each dose.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Cutaneous Lupus Erythematosus Disease and Severity Index-Activity (CLASI-A) Score from Baseline to Week 24Time frame: Baseline to Week 24

Locations

68 sites in 11 countries. Site status is shown where the registry gives one.

  • Arkansas Research Trials

    North Little Rock, Arkansas

  • Wallace Medical Group

    Beverly Hills, California

  • The Center for Dermatology Clinical Research

    Fremont, California

  • Clinical Science Institute

    Santa Monica, California

  • Miami Dermatology & Laser Research

    Miami, Florida

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

  • Detroit Clinical Research Center, PC

    Farmington Hills, Michigan

  • Michigan Dermatology Institute

    Waterford, Michigan

  • Minnesota Clinical Study Center

    New Brighton, Minnesota

  • MediSearch Clinical Trials

    Saint Joseph, Missouri

  • Forest Hills Dermatology

    Forest Hills, New York

  • Ohio State University

    Columbus, Ohio

  • Wright State Physicians

    Fairborn, Ohio

  • Paddington Testing Company, Inc.

    Philadelphia, Pennsylvania

  • Autoimmune Skin Diseases Unit, Dept. of Dermatology

    Philadelphia, Pennsylvania

  • Center for Clinical Studies (Cypress)

    Houston, Texas

  • CIPREC

    Ciudad Autonoma Buenos Aires, Argentina

  • Fundacion Scherbovsky

    Mendoza, Mendoza Province, Argentina

  • IPITEC Instituto de Pesquisa Inovação Tecnológica

    São Paulo, Brazil

  • HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará

    Fortaleza, Ceará, Brazil

  • Hospital Universitário Evangélico Mackenzie

    Água Verde, Paraná, Brazil

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto, CIP - Centro Integrado de Pesquisa

    Sao Jose Rio, Preto Sao Paulo, Brazil

  • Complexo Hospitalar de Niterói

    Niterói, Rio Do Janeiro, Brazil

  • Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A

    Rio de Janeiro, Rio Do Janeiro, Brazil

  • Fundação Universidade de Caxias do Sul - Instituto de Pesquisas em Saúde da Universidade de Caxias do Sul

    Caxias do Sul, Rio Grande do Sul, Brazil

  • Hospital Moinhos de Vento

    Porto Alegre, Rio Grande do Sul, Brazil

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • LMK Serviços Médicos S/S

    Porto Alegre, Rio Grande do Sul, Brazil

  • Universidade Estadual de Campinas

    Campinas, São Paulo, Brazil

  • Hospital Christovão da Gama - Centro de Estudos

    Santo André, São Paulo, Brazil

  • Centro Multidisciplinar de Estudos Clinicos

    São Bernardo do Campo, São Paulo, Brazil

  • IMC - Instituto de Moléstias Cardiovasculares Tatuí

    Tatuí, São Paulo, Brazil

  • DCC 'Sveti Georgi' EOOD

    Haskovo, Bulgaria

  • Ambulatory for specialized medical care - individual practice for specialized medical care - skin and venereal diseases

    Sofia, Bulgaria

  • DCC "Alexandrovska" EOOD

    Sofia, Bulgaria

  • Medical Center Eurohealth EOOD

    Sofia, Bulgaria

  • Alberta DermaSurgery Centre

    Edmonton, Alberta, Canada

  • Brunswick Dermatology Center

    Fredericton, New Brunswick, Canada

  • DermEffects

    London, Ontario, Canada

  • North York Research, Inc

    Toronto, Ontario, Canada

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.